36C25020Q0262.docx

Contract Opportunity Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field Contract Opportunity Special Notice

INFINITY UPGRADE

44131 36C25020Q0262 N 334516 Department of Veterans Affairs Network Contracting Office (NCO) 10 6150 Oak Tree Blvd., Suite 300 Independence OH 44131 Rachelle J. Hamer www.va.gov Department of Veterans Affairs rachelle.hamer@va.gov Contracting Officer

SPECIAL NOTICE

NOTICE OF INTENT TO SOLE SOURCE

Infinity Upgrade The Department of Veterans Affairs, Louis Stokes Medical Center (CLE VAMC), Nuclear Medicine Department, 10701 East Blvd., Cleveland, OH 44106, intends to solicit and negotiate with only one source under the authority of FAR 13.106(b)(i), Soliciting from a single source, there is only one source that can provide the supplies needed. The NAICS code is 325412 with a small business size standard of 1,200. The VA intends to solicit and negotiate with Cepheid, 904 Caribbean Drive, Sunnydale, CA 94089 for an Infinity Upgrade.

The Pathology and Laboratory Medicine Service at Veterans Administration Syracuse, NY is currently using Molecular Diagnostic equipment and technology in the nationwide VA effort to eradicate MRSA from our healthcare network. We perform this MRSA testing using the GeneXpert-16 System manufactured and distributed by Cepheid. Cepheid Inc. has exclusive rights for manufacturing and distributing our current GeneXpert System®, GeneXpert cartridges & diagnostic software for use with the Cepheid Invitro Diagnostic Xpert cartridges for the performance of a number of tests including MRSA. We are now seeking an upgrade that is compatible and is commercially available to this system to continue performing MRSA testing and to expand our test menu to include (but not limited to): GBS, EV, C. diff, MRSA/SA Skin and Soft Tissue (SSTI), MRSA/SA Blood Culture (BC), and H1N1. Additionally, the test menu should preferably be broad and include molecular testing for non-neoplastic and neoplastic conditions such as cancers (BCR-ABL, JAK2, etc.), blood disorders (Factor II/Factor V mutations, etc.), and other infectious diseases (VRE, drug-resistance tuberculosis, and MRSA/SA Nares). The upgrade of this device will allow for an increase of testing from 16 modules to 24 modules. NETSPOT, after radiolabeling with Ga 68, is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.

Other persons may identify their interest and capability to respond to this requirement by Tuesday, January 21, 2020 at 5PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available at this time. All inquiries must be submitted by email to Rachelle Hamer at rachelle.hamer@va.gov.

Enter “36C25020Q0262 | Infinity Upgrade” in the email subject line.